- From: Alan Ruttenberg <alanruttenberg@gmail.com>
- Date: Sun, 17 Feb 2013 13:33:15 -0500
- To: Kerstin Forsberg <kerstin.l.forsberg@gmail.com>
- Cc: public-semweb-lifesci@w3.org, em@zepheira.com, cdsouthan@hotmail.com, brendan.kelleher@karmadata.com, Adam.Jacobs@dianthus.co.uk
Have you looked at https://www.clinicaltrialsregister.eu as well? We did a little work in our group regarding eligibility criteria, and had the impression that the curation was often substantially more detailed at the EU site. In our limited review, both sites, however, suffered from the inability to share the original protocols, even redacted, incompleteness in terms of the criteria recorded as compared to protocol documents, and errors introduced by OCR, such as 10^9 being translated to 109. The licensing and sharing for these resources are also somewhat borked. It's very unclear what can be republished from clinicaltrials.gov, and on top of this we have the licenses added (almost certainly without standing, but adding to the confusion) such as the noncommercial sharealike license added by linkedct.org. I think you are right that the publication of such resources for consumption on the semantic web should be supported by the federal institutions, and in limited cases there is some support. However I think it may be difficult if they can't negotiate the licenses so that users can clearly use (republish, create derivative works, etc) what they publish in innovative (computational ways) and so that they can release more of the primary materials so that we can have crowd-sourced improvements to the content of the published records. Best, Alan On Sat, Feb 16, 2013 at 7:58 AM, Kerstin Forsberg <kerstin.l.forsberg@gmail.com> wrote: > Hi, > a couple of tweets, blog post comments 1) and email exchanges during the > week on moving ClinicalTrials.gov "from strings to things" made me think > this could be a topic for discussion at the upcoming CSHALS. As I'll not be > able to be there in person I'm using this email list to hear your thoughts. > > Background: > We see many nice examples of curated/standardized feeds of CT.gov data, such > as http://linkedct.org, http://www.patientslikeme.com/clinical_trials and > http://www.clinicalcollections.org/trials/ etc.. Most of them do a good job > in turning “strings into things” and a few of them apply the Linked Data > principles. However, I don’t think any of them use http-based URIs to > identify things such as sponsor organization, clinical sites, clinical > investigators, geography, disease, drug, and time. > > I argue that we as a community caring for clinical trials data should push > back to FDA and NLM to get an official, standardized, linked data interface > directly to the CT.gov at source. And yes, also for FDA and NLM to push back > to pharma companies to provide standardized data about our trials with URIs > to identify things instead of all these text strings. And also if pharma > company websites such as http://www.gsk-clinicalstudyregister.com/ and > http://www.astrazenecaclinicaltrials.com/ did the same. > > Given the current movement for clinical trial data transparency 2) I may > think the timing is good. But, potentially challenging both for FDA, NLM and > for the pharma companies. They (we) will all look for practical advice on > what URIs to use for things such as drugs and organizations. > > Thoughts? > Kerstin > > > 1) > http://blog.karmadata.com/2013/02/11/loading-clinical-trials-data-in-ten-minutes-flat/comment-page-1/#comment-20 > 2) > http://www.placebocontrol.com/2013/02/our-new-glass-house-gsks-commitment-to.html
Received on Sunday, 17 February 2013 18:34:13 UTC